Oral motor, communication, and nutritional status of children during intrathecal baclofen therapy: A descriptive pilot study

Archives of Physical Medicine and Rehabilitation

Volumn 84, Issue 4, 2003, Pages 500-506

  Bjornson, Kristie F ^a,b   McLaughlin, John F ^a   Loeser, John D ^a   Nowak Cooperman, Kim M ^a   Russel, Mark ^a   Bader, Kathy A ^a   Desmond, StarRina A ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Baclofen; Cerebral palsy; Communication; Rehabilitation

Indexed keywords

BACLOFEN;

APPETITE; ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; DEFECATION; DRINKING; DYSARTHRIA; FEEDING; FEMALE; HUMAN; MALE; NUTRITIONAL STATUS; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; SALIVATION; SPASTICITY; SPEECH;

EID: 0037390517     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1053/apmr.2003.50030     Document Type: Article

References (28)

1. Samson-Fang LJ, Stevenson RD. Identification of malnutrition in children with cerebral palsy: poor performance of weight-for-height centiles. Dev Med Child Neurol 2000;42:162-8.
2. Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 1997;6:S1-13.
3. Haley SM, Inacio CA. Evaluation of spasticity and its effect on motor function. In: Glenn MB, Whyte J, editors. The practical management of spasticity in adults and children. Philadelphia: Lea & Febiger; 1990. p 70-96.
4. Knutsson E. Assessment of motor function in spasticity. Triangle 1982;21:13-20.
5. Bar-Or O. Pediatric sports medicine for the practitioner. New York: Springer-Verlag; 1983.
6. Leonard EL. Early motor development and control: foundations for independent walking. In: Smidt GL, editor. Gait in rehabilitation, New York: Churchill Livingstone; 1990. p 121-40.
7. Rab GT. Diplegic gait: is there more than spasticity? In: Sussman MD, editor. The diplegic child. Rosemont (IL): American Academy of Orthopedic Surgeons; 1992. p 99-110.
8. Bax M. Eating is important [editorial]. Dev Med Child Neurol 1989;31:285-6.
9. Reilly S, Skuse D. Characteristics and management of feeding problems of young children with cerebral palsy. Dev Med Child Neurol 1992;34:379-88.
10. Bobath K. A neurological basis for the treatment of cerebral palsy. Clin Dev Med 1980;75:1-5.
11. Rosenbloom L, Sullivan PB. The nutritional and neurodevelopmental consequences of feeding difficulties in disabled children. In: Sullivan PB, Rosenbloom L, editors. Feeding the disabled child. London: Mac Keith Pr; 1996. p 33-9.
12. Sullivan PB, Rosenbloom L. The causes of feeding difficulties in disabled children. In: Sullivan PB, Rosenbloom L, editors. Feeding the disabled child. London: Mac Keith Pr; 1996. p 23-32.
13. Yost J, McMillan P. Communication disorders. In: Thompson GH, Rubin IL, Bilenker RM, editors. Comprehensive management of cerebral palsy. New York: Grune & Stratton; 1983. p 157-67.
14. Hopkins T, Bice HV, Colton K. Evaluation and education of the cerebral palsied child. Washington (DC): International Council for Exceptional Children; 1954.
15. Ingram TT. Pediatric aspects of cerebral palsy. Edinburgh: Edinburgh Pr; 1964.
16. Wolfe WA. A comprehensive evaluation of 50 cases of cerebral palsy. J Speech Hear Disord 1950;15:234.
17. Dralle D, Muller H, Zierski J, Klug N. Intrathecal baclofen for spasticity [letter]. Lancet 1985;2:1003.
18. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991;265:1418-22.
19. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993;270:2475-7.
20. Krach LE, Gilmartin R, Bruce D, et al. Functional changes noted following treatment of individuals with cerebral palsy with intrathecal baclofen [abstract]. Dev Med Child Neurol 1997;39 Suppl 75:12-3.
21. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000;42:634-45.
22. Gilmartin R, Bruce D, Storrs B, et al. Multicenter trial: intrathecal baclofen for management of spastic cerebral palsy. J Child Neurol 2000;15:71-7.
23. Campbell S, Almeida GL, Penn RD, Corocos DM. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 1995;75:352-62.
24. Wien HD. Spasticity in children with cerebral palsy: a retrospective review of the effect of intrathecal baclofen. Issues Compr Pediatr Nurs 1998;21(2):49-61.
25. Mason C, Gilpin P, McGowan S, Rossiter D. The effect of intrathecal baclofen on functional intelligibility of speech. Int J Lang Commun Disord 1998;33 Suppl:24-5.
26. National Institute of Child Health and Human Development, US Department of Health and Human Services. Research plan for the National Center for Medical Rehabilitation Research. Washington (DC): National Institute of Child Health and Human Development; 1993. NIH Publication No. 93-3509.
27. Kenny DJ, Koheil RM, Greenberg J, et al. Development of a multidisciplinary feeding profile for children who are dependent feeders. Dysphagia 1989;4:16-28.
28. Yorkston KM, Beukelman DR. Assessment of intelligibility of dysarthric speech. Austin (TX): Pro-Ed; 1981.